Literature DB >> 3083740

Three-month follow-up of arterial blood gas determinations in candidates for long-term oxygen therapy. A multicentric study.

P Levi-Valensi, E Weitzenblum, J L Pedinielli, J L Racineux, H Duwoos.   

Abstract

One hundred seventeen patients with severe chronic obstructive pulmonary disease whose PaO2 in a stable clinical state ranged from 41 to 59 mmHg, were included in a multicentric controlled study on the effects of long-term O2 therapy (LTO), and the results of the 3-month probationary period are given here. Arterial blood gases were checked every month in order to assess the stability of hypoxemia. Time 0 represented the beginning and T3 the end of the probationary period. Patients whose PaO2 at T3 was still between 41 and 59 mmHg could be accepted for the long-term study (Group A), whereas patients whose PaO2 had increased over 59 mmHg were excluded (Group B). Only 77 patients could be followed up regularly from T0 to T3 (40 patients were lost to follow-up, missed some visits, or suffered from acute exacerbations of the disease) and 23 of them had a PaO2 at T3 that exceeded 59 mmHg (Group B), allowing the inclusion of 54 patients (Group A) in the long-term study. Patients in Groups A and B did not differ with regard to pulmonary volumes, PaCO2 at T0 or a past history of right heart failure. Arterial O2 tension at T0 was slightly and significantly (p less than 0.02) lower in Group A (51.3 +/- 5.5 mmHg) than in Group B (54.5 +/- 3.8 mmHg), but there was an important overlapping of individual results from one group to another.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083740     DOI: 10.1164/arrd.1986.133.4.547

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

1.  Got a match? Home oxygen therapy in current smokers.

Authors:  Y Lacasse; J LaForge; F Maltais
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

Review 2.  E-cigarette use in patients receiving home oxygen therapy.

Authors:  Yves Lacasse; Martin Légaré; François Maltais
Journal:  Can Respir J       Date:  2015 Mar-Apr       Impact factor: 2.409

Review 3.  Long term domiciliary oxygen therapy in chronic obstructive pulmonary disease.

Authors:  M I Walters; P R Edwards; J C Waterhouse; P Howard
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

4.  Changes in nocturnal oximetry after treatment of exacerbations in cystic fibrosis.

Authors:  M B Allen; A F Mellon; E J Simmonds; R L Page; J M Littlewood
Journal:  Arch Dis Child       Date:  1993-08       Impact factor: 3.791

5.  Review of the prescription of domiciliary long term oxygen therapy in Scotland.

Authors:  D Morrison; K Skwarski; W MacNee
Journal:  Thorax       Date:  1995-10       Impact factor: 9.139

6.  The risk of burn injury during long-term oxygen therapy: a 17-year longitudinal national study in Sweden.

Authors:  Hanan A Tanash; Fredrik Huss; Magnus Ekström
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-13

Review 7.  Long-term oxygen therapy: are we prescribing appropriately?

Authors:  Rosa Güell Rous
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

8.  Reassessment of Home Oxygen Prescription after Hospitalization for Chronic Obstructive Pulmonary Disease. A Potential Target for Deimplementation.

Authors:  Laura J Spece; Eric M Epler; Kevin Duan; Lucas M Donovan; Matthew F Griffith; Stephanie LaBedz; Neeta Thakur; Renda Soylemez Wiener; Jerry A Krishnan; David H Au; Laura C Feemster
Journal:  Ann Am Thorac Soc       Date:  2021-03

Review 9.  Which patients with moderate hypoxemia benefit from long-term oxygen therapy? Ways forward.

Authors:  Magnus Ekström; Thomas Ringbaek
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-09

10.  Long-term oxygen therapy in COPD patients: population-based cohort study on mortality.

Authors:  Nikolay Pavlov; Alan Gary Haynes; Armin Stucki; Peter Jüni; Sebastian Robert Ott
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.